Day June 14, 2026
HMN 2026: What is the possible new ally in the opioid crisis
HMN 2026: What is the first-in-class drug candidate for chronic itch
Developing clinical candidate drugs for treating cholestatic itch by targeting the “itch receptor” MRGPRX4. Credit: Nature Chemical Biology (2026). DOI: 10.1038/s41589-026-02195-0 Chronic itch is often described as an “invisible torment.” It can persist for weeks or months, severely affecting sleep,…
HMN 2026: How ‘housekeeping’ immune cells are attacking live melanoma
HMN 2026: What is the brain circuit that helps us ‘change gears’
HMN 2026: How Schwann cells may trigger NF1 pain before tumors appear
HMN 2026: How School recess is a health necessity, not a reward
HMN 2026: How Gene changes reshape signaling in developing neurons
HMN 2026: What is the impact of atopic dermatitis on educational and career choices
HMN 2026: How Saliva could flag one of the deadliest and most baffling cancers sooner
HMN 2026: How Sabiá virus has been circulating in Brazil for 142 years and mutating
HMN 2026: How Rx Kids improved outcomes for Flint babies, families
HMN 2026: How Rural siblings of people with neurodevelopmental conditions are left to go it alone
HMN 2026: How Rural health research could bypass RCT hurdles with real-world data
HMN 2026: How RSV mutations are tied to severe childhood cases uncovered after 2022 surge
Human Respiratory Syncytial Virus (RSV) 3D rendering of respiratory syncytial virus (RSV)—a common contagious virus that infects the human respiratory tract—colorized in Halloween-appropriate colors (the viral envelope is purple, G- glycoproteins are light blue, and F-glycoproteins are orange). F-glycoproteins allow…
HMN 2026: How Routine heart test can track how kids grow and mature
HMN 2026: How Rollback of PFAS drinking water standards raises safety fears
HMN 2026: What is the protective role of a key protein in pancreatitis
HMN 2026: How robots are becoming surgical assistants
HMN 2026: How Robot-assisted simple prostatectomy, laser enucleation are both safe for large-volume benign prostatic hyperplasia
HMN 2026: How RNA therapy for genetic heart failure moves closer to patients after lab gains
Credit: Signal Transduction and Targeted Therapy (2026). DOI: 10.1038/s41392-026-02791-5 Using patient-derived cardiac tissue and stem cell-based models, the team of translational researchers demonstrated that targeting the genetic cause of disease improved cellular abnormalities and identified the biological pathways involved. The…
HMN 2026: What extremely preterm birth teaches us about the brain
HMN 2026: How Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies
HMN 2026: how people use AI for mental health support—and their concerns about it
HMN 2026: How brain changes are linked to alcohol addiction recovery
HMN 2026: How Reusable catheters are a safe choice that could cut antibiotic use and NHS costs
HMN 2026: How Residual risks of liver cancer persist after hepatitis C cure,
Cumulative incidence of HCC with 95%?CI in patients with MASLD with different hepatic steatosis grades. Credit: Gut (2026). DOI: 10.1136/gutjnl-2025-337275 National Taiwan University Hospital (NTUH), in collaboration with multiple medical centers across Taiwan, has found that patients with hepatitis C…
HMN 2026: How Repetitive TMS is effective, safe for poststroke neurogenic overactive bladder
Low-frequency contralesional repetitive transcranial magnetic stimulation (rTMS) is effective and safe for poststroke neurogenic overactive bladder (OAB), according to a study published in Neurorehabilitation & Neural Repair. Mohammed Usman Ali, P.T., Ph.D., from The Hong Kong Polytechnic University, and colleagues…
